Legend Biotech (LEGN) Net Cash Flow (QoQ) (2019 - 2025)
Legend Biotech (LEGN) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,507.18% |
| Sep 30, 2025 | 105.27% |
| Jun 30, 2025 | -216.93% |
| Mar 31, 2025 | 190.17% |
| Dec 31, 2024 | -166.14% |
| Sep 30, 2024 | 136.98% |
| Jun 30, 2024 | -83.34% |
| Mar 31, 2024 | -221.42% |
| Dec 31, 2023 | 216.30% |
| Sep 30, 2023 | -147.12% |
| Jun 30, 2023 | 561.71% |
| Mar 31, 2023 | -383.05% |
| Dec 31, 2022 | -105.90% |
| Sep 30, 2022 | 15,089.35% |
| Jun 30, 2022 | 100.92% |
| Mar 31, 2022 | -345.24% |
| Dec 31, 2021 | 53.13% |
| Sep 30, 2021 | -297.59% |
| Jun 30, 2021 | 272.58% |
| Mar 31, 2021 | 82.26% |